PRCT PROCEPT BioRobotics Corp

CIK 0001588978 48 ready 8-Ks latest October 2, 2026, 4:46 PM ET RSS · JSON

Activity: NORMAL 2 filings / 30d vs 1 baseline

Ready 8-Ks 48

Latest filing October 2, 2026, 4:46 PM ET

Top materiality 0.85

Event mix earnings ×22 · other_material ×12 · leadership ×6

Sentiment 21 pos · 0 neg · 27 neu

Latest earnings reported 2026-Q1

Executive change recent →

Recent 8-K filings for PRCT

Highest-materiality recent filing

PROCEPT BioRobotics Q4 revenue up 57% to $68.2M; guides FY2025 revenue ~$320M (+42%)

February 25, 2025, 6:59 PM ET earnings materiality 0.85 positive item 2.02 item 9.01

Q4 rev $68.2M (+57% YoY); US system rev $27.6M (+67%); handpiece rev $29.3M (+36%).
FY2024 rev $224.5M (+65%); net loss narrowed to $91.4M from $105.9M; adj EBITDA loss $61.1M vs $86.5M.

Read filing →

October 2, 2026, 4:46 PM ET leadership materiality 0.35 neutral item 5.02 item 9.01

PROCEPT BioRobotics appoints Dr. Michael Mack to board, increasing size from nine to ten directors

The board approved increasing its size from nine to ten members and appointed Dr. Michael Mack as a Class II director, effective October 2, 2026.
September 24, 2026, 4:44 PM ET debt materiality 0.20 neutral item 1.01 item 9.01

PROCEPT BioRobotics extends CIBC term loan maturity by 12 months to Oct 1, 2028

Third Amendment to Loan and Security Agreement signed September 23, 2026 with Canadian Imperial Bank of Commerce.
August 4, 2026, 4:12 PM ET earnings materiality 0.75 positive item 2.02 item 9.01

PROCEPT Q2 revenue $94.5M (+19% YoY); net loss $26.9M; reiterates FY guidance

Revenue $94.5M, up 19% YoY; U.S. procedures over 13,100 (+21% YoY).
June 10, 2026, 4:33 PM ET other material materiality 0.15 neutral item 5.07 ◈ Shareholder Votes ×3

Annual meeting: director nominees elected, auditor ratified, say-on-pay approved

Directors Desai (28.4M for, 8.5M withheld), Garrett (29.2M for, 7.8M withheld), Moll (36.5M for, 0.5M withheld) elected.
April 29, 2026, 7:59 PM ET earnings materiality 0.60 neutral item 2.02 item 9.01 ◈ Earnings Releases

PROCEPT BioRobotics Reports Q1 2026 Revenue of $83.1M, Up 20% YoY; Net Loss Widens to $31.6M

Total revenue $83.1M, +20% YoY; U.S. procedures 12,200, +30% YoY.
March 6, 2026, 6:59 PM ET leadership materiality 0.35 neutral item 5.02 item 9.01

Appoints Daniel Puckett as new board member and Audit Committee member

Board expanded from 8 to 9 members; Puckett appointed effective March 5, 2026.
February 26, 2026, 6:59 PM ET other material materiality 0.20 neutral item 7.01 item 9.01

PROCEPT BioRobotics holds Investor Day; no specific data disclosed in 8-K exhibit excerpt

Investor Day held Feb 26, 2026 at NASDAQ HQ; presentation furnished as Exhibit 99.1.
February 25, 2026, 6:59 PM ET earnings materiality 0.75 neutral item 2.02 item 9.01

PROCEPT BioRobotics Q4 rev $76.4M (+12% YoY), net loss $29.8M; FY26 guidance $390-410M

Q4 total revenue $76.4M (+12% YoY); U.S. procedures ~12,200 (+69% YoY).
November 4, 2025, 6:59 PM ET earnings materiality 0.80 positive item 2.02 item 9.01

PROCEPT Q3 revenue $83.3M (+43% YoY); issues FY2026 guidance $410M-$430M

Q3 total revenue $83.3M, up 43% YoY; U.S. handpiece/consumables $44.4M (+50% YoY).
September 18, 2025, 7:59 PM ET other material materiality 0.45 neutral item 5.02 item 9.01

PROCEPT BioRobotics modifies severance for non-CEO execs: severance doubled to 12 months, lump sum on change of control

Severance period for non-CEO execs increased from 6 to 12 months for termination without cause not tied to a change of control.
August 6, 2025, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01

PROCEPT Q2 revenue $79.2M (+48% YoY); raises FY25 guidance; appoints new CEO

Q2 total revenue $79.2M, up 48% YoY; U.S. handpiece/consumables $43.1M (+58%).
July 25, 2025, 7:59 PM ET leadership materiality 0.75 positive item 2.02 item 5.02 item 7.01 item 9.01

PROCEPT BioRobotics appoints Larry Wood as CEO, pre-announces Q2 revenue of $79.2M (+48% YoY)

Larry L. Wood becomes President and CEO effective Sept 2, 2025; succeeds Reza Zadno who retires.
June 11, 2025, 7:59 PM ET other materiality 0.15 neutral item 5.07

Procept BioRobotics stockholders elect directors, ratify auditor, approve say-on-pay

Directors elected: Little (31.8M votes for), Prescott (41.7M), Wood (39.8M); broker non-votes 4.35M.
April 25, 2025, 7:59 PM ET other material materiality 0.05 neutral item 7.01 item 9.01

Procept BioRobotics presents at AUA investor event; no financial details in filing excerpt

Company furnished presentation slides for AUA annual meeting on April 25, 2025.
April 24, 2025, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01

PROCEPT BioRobotics Q1 revenue up 55% to $69.2M; raises FY2025 guidance to $323M

Total revenue $69.2M, +55% YoY; U.S. revenue $60.3M (+50%); international $8.9M (+104%).
February 25, 2025, 6:59 PM ET earnings materiality 0.85 positive item 2.02 item 9.01

PROCEPT BioRobotics Q4 revenue up 57% to $68.2M; guides FY2025 revenue ~$320M (+42%)

Q4 rev $68.2M (+57% YoY); US system rev $27.6M (+67%); handpiece rev $29.3M (+36%).
October 31, 2024, 7:59 PM ET other material materiality 0.60 neutral item 8.01 item 9.01

PROCEPT BioRobotics issues ~1.92M shares at $91/share, nets ~$163.8M in public offering

Company sold 1,923,076 shares at $91 per share; net proceeds to company were ~$163.8M after discounts and expenses.
October 28, 2024, 7:59 PM ET earnings materiality 0.85 positive item 2.02 item 9.01

PROCEPT BioRobotics Q3 revenue $58.4M (+66% YoY); raises 2024 revenue and EBITDA guidance

Q3 revenue $58.4M, up 66% YoY; U.S. handpiece+consumables $29.6M (+74%).
August 21, 2024, 7:59 PM ET regulatory materiality 0.65 positive item 8.01

PROCEPT BioRobotics receives FDA 510(k) clearance for HYDROS Robotic System

HYDROS features FirstAssist AI for AI-powered treatment planning using real-world procedure data.
August 1, 2024, 7:59 PM ET earnings materiality 0.85 positive item 2.02 item 9.01

PROCEPT BioRobotics Q2 revenue $53.4M (+61% YoY); raises FY2024 revenue and EBITDA guidance

Total revenue $53.4M (+61% YoY); U.S. handpiece & consumables $27.3M (+101% YoY).
July 19, 2024, 7:59 PM ET leadership materiality 0.50 neutral item 5.02 item 9.01 ◈ executive_change ×2

Director Krummel resigns; Thomas M. Prescott appointed new board member and chairperson

Dr. Thomas Krummel resigned from Board and Compensation Committee effective July 18, 2024; no disagreement with company.
June 5, 2024, 7:59 PM ET other materiality 0.00 neutral item 5.07

Procept BioRobotics shareholders elect three directors, ratify auditor, approve executive compensation at annual meeting

Amy Dodrill, Taylor Harris, and Reza Zadno elected to board with majority vote.
May 3, 2024, 7:59 PM ET other material materiality 0.10 neutral item 7.01 item 9.01

PROCEPT BioRobotics furnishes investor presentation; no specific financial data disclosed

Company will present at investor conferences starting May 3, 2024, using slides furnished as Exhibit 99.1.
May 1, 2024, 7:59 PM ET earnings materiality 0.30 neutral item 2.02 item 9.01 ◈ Earnings Releases

PROCEPT BioRobotics announces Q1 2024 earnings; press release not included in filing

The 8-K filing references a press release dated May 1, 2024 for Q1 2024 financial results.
April 19, 2024, 7:59 PM ET leadership materiality 0.30 neutral item 5.02 item 9.01 ◈ executive_change ×2

Director Colby Wood resigns; Larry Wood appointed to board and audit committee

Colby Wood resigned as director and Audit Committee member effective April 18, 2024; no disagreement cited.
February 27, 2024, 6:59 PM ET earnings materiality 0.30 neutral item 2.02 item 9.01 ◈ Earnings Releases

PROCEPT BioRobotics issues Q4 2023 earnings release; key metrics not disclosed in filing body

Press release furnished as Exhibit 99.1 contains full financial results; not included in extracted text.
November 1, 2023, 7:59 PM ET earnings materiality 0.80 positive item 2.02 item 9.01 ◈ Earnings Releases ×2

PROCEPT BioRobotics Q3 revenue $35.1M (+72% YoY); raises FY2023 guidance to $133.5M

Revenue $35.1M, up 72% YoY; U.S. handpiece/consumables $17.0M, up 113%.
September 12, 2023, 7:59 PM ET other material materiality 0.10 neutral item 8.01

PROCEPT BioRobotics relocates HQ to San Jose, CA

New corporate headquarters at 150 Baytech Drive, San Jose, CA 95134 effective September 12, 2023.
August 4, 2023, 7:59 PM ET other material materiality 0.75 neutral item 8.01 item 9.01

PROCEPT BioRobotics closes public offering of 5.1M shares, netting $161.3M

Underwriting agreement with BofA Securities, Piper Sandler, Cowen for 4.42M shares at $33.92/share public price.
July 27, 2023, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01 ◈ Earnings Releases ×2

PROCEPT BioRobotics Q2 revenue $33.1M (+98% YoY); raises FY2023 guidance to $131M

Record 40 U.S. AquaBeam systems sold in Q2; U.S. system revenue $14.8M (+74% YoY).
June 15, 2023, 7:59 PM ET other materiality 0.15 neutral item 5.07 ◈ Shareholder Votes ×3

PROCEPT BioRobotics reports annual meeting voting results; all proposals passed

All three director nominees (Moll, Desai, Garrett) elected with 29.3M to 25.2M votes for.
June 2, 2023, 7:59 PM ET debt materiality 0.55 positive item 1.01 item 2.03 item 9.01 ◈ Material Agreements

PROCEPT BioRobotics reduces required CIBC deposit to $90M, frees excess cash

Loan amendment lowers minimum cash at CIBC to lesser of $90M or all non-operating cash.
April 28, 2023, 7:59 PM ET other material materiality 0.10 neutral item 7.01 item 9.01

PROCEPT BioRobotics presents at AUA 2023; no new financial data in filing

Company to present at American Urology Association Annual Meeting on April 28, 2023.
April 27, 2023, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01 ◈ Earnings Releases ×2

PROCEPT BioRobotics Q1 revenue up 72% to $24.4M; raises FY2023 revenue guidance to $128M

Total revenue $24.4M (+72% YoY); U.S. handpiece/consumables $11.8M (+165% YoY).
February 28, 2023, 6:59 PM ET earnings materiality 0.75 neutral item 2.02 item 9.01

PROCEPT BioRobotics Q4 revenue up 135% YoY to $23.8M; guides 2023 revenue ~$125M

Q4 2022 revenue $23.8M (+135% YoY); full year revenue $75.0M (+118% YoY).
January 9, 2023, 6:59 PM ET earnings materiality 0.65 positive item 2.02 item 9.01 ◈ Earnings Releases

PROCEPT BioRobotics pre-announces Q4 rev ~$23.6-23.8M, FY2022 rev ~$74.8-75.0M (+117% YoY)

Q4 2022 revenue expected $23.6M-$23.8M, up from $10.1M in Q4 2021.
November 3, 2022, 7:59 PM ET earnings materiality 0.85 positive item 2.02 item 9.01 ◈ Earnings Releases

PROCEPT BioRobotics Q3 revenue $20.3M (+135% YoY), raises 2022 guidance to ~$72.5M

Total revenue $20.3M, +135% YoY; US system rev $9.8M (+95%), handpiece $8.0M (+267%).
October 11, 2022, 7:59 PM ET debt materiality 0.60 positive item 1.01 item 1.02 item 2.03 item 9.01

PROCEPT BioRobotics closes $52M term loan with CIBC, repays $50M Oxford facility

Entered $52M senior secured term loan with CIBC; fully drawn on Oct 6, 2022.
August 4, 2022, 7:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01

PROCEPT BioRobotics Q2 revenue up 97% to $16.7M; raises FY22 revenue guidance to $66-68M

Q2 2022 total revenue $16.7M, +97% YoY; U.S. system revenue $8.5M (+79%), handpiece and consumables $5.7M (+246%).
June 8, 2022, 7:59 PM ET other materiality 0.10 neutral item 5.07

PROCEPT BioRobotics annual meeting elects three directors and ratifies auditor

Thomas Krummel, M.D. elected with 27,027,803 votes for and 1,904,365 withheld; broker non-votes 3,025,300.
May 13, 2022, 7:59 PM ET other material materiality 0.25 neutral item 7.01 item 9.01

PROCEPT BioRobotics presents at AUA 2022 Annual Meeting; no material new information disclosed.

Furnished presentation slides for investor meetings at AUA 2022 on May 13, 2022.
May 5, 2022, 7:59 PM ET earnings materiality 0.80 positive item 2.02 item 9.01

PROCEPT BioRobotics Q1 revenue $14.2M (+97% YoY); raises FY2022 revenue guidance to $58-62M

Q1 total revenue $14.2M, +97% YoY; U.S. system revenue $7.8M (+70%), handpiece & consumables $4.4M (+174%).
March 8, 2022, 6:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01

PROCEPT BioRobotics Q4 revenue $10.1M (+216% YoY); guides FY2022 revenue $54-58M

Revenue $10.1M in Q4 2021, up from $3.2M YoY; full year $34.5M vs $7.7M.
January 11, 2022, 6:59 PM ET earnings materiality 0.70 positive item 2.02 item 9.01

PROCEPT BioRobotics announces preliminary Q4 revenue of $9.8-10.1M, FY 2021 revenue $34.1-34.4M

Q4 2021 revenue expected $9.8M-$10.1M, up from $3.2M in Q4 2020.
January 4, 2022, 6:59 PM ET other material materiality 0.60 neutral item 1.01 item 5.02 item 9.01 ◈ executive_change

PROCEPT BioRobotics signs 10-year lease for 158,221 sq ft San Jose facility; appoints Mary Garrett to board

Lease for 158,221 rentable sq ft in San Jose, CA; term 122 months starting on or before Dec 31, 2022.
November 4, 2021, 7:59 PM ET earnings materiality 0.70 positive item 2.02 item 9.01

PROCEPT Q3 revenue $8.7M up 314% YoY; raises FY 2021 guide to $33.0-$33.3M

Total revenue of $8.7M vs. $2.1M in Q3 2020; U.S. system revenue $5.0M vs. $0.6M.
October 26, 2021, 7:59 PM ET leadership materiality 0.30 neutral item 5.02 item 9.01 ◈ executive_change

PROCEPT BioRobotics appoints Elisabeth Sandoval to Board of Directors

Board expanded from eight to nine members; Sandoval appointed as Class I director effective Oct. 21, 2021.
September 21, 2021, 7:59 PM ET other material materiality 0.50 neutral item 5.03 item 9.01

PROCEPT BioRobotics adopts amended charter/bylaws upon IPO closing Sep 17, 2021

Authorized common stock increased to 300M shares; 10M shares of undesignated preferred stock authorized.